In summary, neither common nor rare variants in SOAT1/2 are associated with lipoprotein levels, atherosclerosis, or Alzheimer’s disease, despite abundant biochemical and mouse studies showing effects on related phenotypes. Here, SOAT1 is linked to early-onset autosomal dominant Alzheimer disease.